Hangzhou Alltest Biotech Co (SHSE:688606) Total Stockholders Equity : ¥3,838.6 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Alltest Biotech Co Total Stockholders Equity?

Hangzhou Alltest Biotech Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥3,838.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hangzhou Alltest Biotech Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥48.42. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hangzhou Alltest Biotech Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.01.

Hangzhou Alltest Biotech Co Total Stockholders Equity Historical Data

The historical data trend for Hangzhou Alltest Biotech Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Alltest Biotech Co Total Stockholders Equity Chart

Hangzhou Alltest Biotech Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

293.20

972.36

3,273.64

4,166.23

3,827.25

Hangzhou Alltest Biotech Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															4,213.20	3,726.68	3,746.47	3,827.25	3,838.62

Hangzhou Alltest Biotech Co (SHSE:688606) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hangzhou Alltest Biotech Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3838.616	-	0)	/	79.2809
	=	48.42

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hangzhou Alltest Biotech Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.921	+	9.707)	/	3838.616
	=	0.01

Hangzhou Alltest Biotech Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hangzhou Alltest Biotech Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Alltest Biotech Co (SHSE:688606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou Alltest Biotech Co Ltd (SHSE:688606) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 550, Yinhai Street, Baiyang Street, Hangzhou Economic and Technological Development Zone, Building 3-5, Zhejiang Province, Hangzhou, CHN, 310018

Website

http://www.alltests.com.cn

Hangzhou Alltest Biotech Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents.

Executives

Fu Yan Ping	senior management
Lu Wei Ke	Directors, senior managers, core technical personn
Gao Fei	Directors, senior managers, core technical personn

Hangzhou Alltest Biotech Co (SHSE:688606) Headlines

No Headlines